215 related articles for article (PubMed ID: 34650057)
21. Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension.
Yuan K; Shao NY; Hennigs JK; Discipulo M; Orcholski ME; Shamskhou E; Richter A; Hu X; Wu JC; de Jesus Perez VA
Am J Pathol; 2016 Sep; 186(9):2500-14. PubMed ID: 27456128
[TBL] [Abstract][Full Text] [Related]
22. Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo.
Li W; Hao J; Zhang L; Cheng Z; Deng X; Shu G
J Agric Food Chem; 2017 Jul; 65(29):5961-5972. PubMed ID: 28654261
[TBL] [Abstract][Full Text] [Related]
23. Dual role of pericyte α6β1-integrin in tumour blood vessels.
Reynolds LE; D'Amico G; Lechertier T; Papachristodoulou A; Muñoz-Félix JM; De Arcangelis A; Baker M; Serrels B; Hodivala-Dilke KM
J Cell Sci; 2017 May; 130(9):1583-1595. PubMed ID: 28289267
[TBL] [Abstract][Full Text] [Related]
24. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
26. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
Hui L; Zhang J; Guo X
Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
[TBL] [Abstract][Full Text] [Related]
27. Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer.
Kim S; Jang JY; Koh J; Kwon D; Kim YA; Paeng JC; Ock CY; Keam B; Kim M; Kim TM; Heo DS; Chung DH; Jeon YK
J Exp Clin Cancer Res; 2019 Nov; 38(1):462. PubMed ID: 31718692
[TBL] [Abstract][Full Text] [Related]
28. Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics.
Durham JT; Surks HK; Dulmovits BM; Herman IM
Am J Physiol Cell Physiol; 2014 Nov; 307(9):C878-92. PubMed ID: 25143350
[TBL] [Abstract][Full Text] [Related]
29. Jolkinolide B inhibits glycolysis by downregulating hexokinase 2 expression through inactivating the Akt/mTOR pathway in non-small cell lung cancer cells.
Gao X; Han H
J Cell Biochem; 2018 Jun; 119(6):4967-4974. PubMed ID: 29384225
[TBL] [Abstract][Full Text] [Related]
30. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
[TBL] [Abstract][Full Text] [Related]
31. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glycolytic activator PFKFB3 suppresses tumor growth and induces tumor vessel normalization in hepatocellular carcinoma.
Matsumoto K; Noda T; Kobayashi S; Sakano Y; Yokota Y; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Umeshita K; Doki Y; Eguchi H
Cancer Lett; 2021 Mar; 500():29-40. PubMed ID: 33307155
[TBL] [Abstract][Full Text] [Related]
33. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
Jin F; Wang Y; Zhu Y; Li S; Liu Y; Chen C; Wang X; Zen K; Li L
Sci Rep; 2017 Jun; 7(1):3089. PubMed ID: 28596599
[TBL] [Abstract][Full Text] [Related]
34. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism.
Chai F; Li Y; Liu K; Li Q; Sun H
J Cell Physiol; 2019 Feb; 234(2):1937-1946. PubMed ID: 30144070
[TBL] [Abstract][Full Text] [Related]
35. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
36. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
[TBL] [Abstract][Full Text] [Related]
37. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.
Dai W; Wang F; Lu J; Xia Y; He L; Chen K; Li J; Li S; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Abudumijiti H; Chen R; Zhang R; Zhou L; Zhou Z; Zhu R; Yang J; Wang C; Zhang H; Zhou Y; Xu L; Guo C
Oncotarget; 2015 May; 6(15):13703-17. PubMed ID: 25938543
[TBL] [Abstract][Full Text] [Related]
38. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway.
Li W; Ma X; Li N; Liu H; Dong Q; Zhang J; Yang C; Liu Y; Liang Q; Zhang S; Xu C; Song W; Tan S; Rong P; Wang W
Exp Cell Res; 2016 Dec; 349(2):320-327. PubMed ID: 27829129
[TBL] [Abstract][Full Text] [Related]
40. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.
Patra KC; Wang Q; Bhaskar PT; Miller L; Wang Z; Wheaton W; Chandel N; Laakso M; Muller WJ; Allen EL; Jha AK; Smolen GA; Clasquin MF; Robey B; Hay N
Cancer Cell; 2013 Aug; 24(2):213-228. PubMed ID: 23911236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]